Peer-reviewedCC BY-NC 3.0Clinical and Molecular Hepatology
Risk assessment of cardiovascular disease-related mortality in metabolic dysfunction-associated steatotic liver disease
6 affiliations
- 1Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA
- 2Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA
- 3Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Morningside and West, New York, NY, USA
- 4Department of Medicine, Bridgeport Hospital, Yale New Haven Health, Bridgeport, CT, USA
- 5Department of Medicine, Division of Gastroenterology and Hepatology, University of Arizona College of Medicine, Phoenix, AZ, USA
- 6Department of Internal Medicine, Division of Gastroenterology and Hepatology, Banner University Medical Center, Phoenix, AZ, USA
Related
- Metabolic Dysfunction-Associated Fatty Liver Disease-Cardiovascular-Kidney-Metabolic (MAFLD-CKM): A Modified Framework to Predict Long-Term Mortality.
- Metabolic and Renal Dysfunction Are Associated With Intraplaque Lipid Burden Assessed by Near‐Infrared Spectroscopy Intravascular Ultrasound: Insights Into the Cardiovascular–Kidney–Metabolic Axis
- MASLD VCTE-C cohort: a prospective multicenter study linking liver fibrosis to cardiovascular outcomes in patients with metabolic dysfunction–associated steatotic liver disease
- Feasibility of multidomain cardiovascular-kidney-metabolic biomarker assessment for in-hospital mortality in older heart failure inpatients: an exploratory retrospective cohort study.
- Association between grip strength and cause-specific mortality in metabolic dysfunction-associated steatotic liver disease
BibTeX
@article{kim2026risk,
title = {{Risk assessment of cardiovascular disease-related mortality in metabolic dysfunction-associated steatotic liver disease}},
author = {Donghee Kim and Pojsakorn Danpanichkul and Do Han Kim and Donghyun Ko and Karn Wijarnpreecha and Aijaz Ahmed},
journal = {Clinical and Molecular Hepatology},
year = {2026},
month = jun,
doi = {10.3350/cmh.2026.0496},
url = {https://doi.org/10.3350/cmh.2026.0496},
note = {CC BY-NC 3.0},
}
RIS
TY - JOUR
TI - Risk assessment of cardiovascular disease-related mortality in metabolic dysfunction-associated steatotic liver disease
AU - Donghee Kim
AU - Pojsakorn Danpanichkul
AU - Do Han Kim
AU - Donghyun Ko
AU - Karn Wijarnpreecha
AU - Aijaz Ahmed
PY - 2026
DA - 2026/06/05
JO - Clinical and Molecular Hepatology
DO - 10.3350/cmh.2026.0496
UR - https://doi.org/10.3350/cmh.2026.0496
SN - 2287-2728
SN - 2287-285X
ER -